Treatment with the FAK inhibitor, TAE226, was shown to induce dormancy in laryngeal SCC cells51, siRNA inhibition of FAK induced decreased proliferation in oral squamous cell carcinoma cells52, and elevated FAK expression in slow-growing SCC25 cells caused an increase in cell growth53. The gene discussed is PTK2; the disease is oral cavity squamous cell carcinoma.